Spots Global Cancer Trial Database for cannabidiol
Every month we try and update this database with for cannabidiol cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| RCT of CBD for Anxiety in Advanced Breast Cancer | NCT04482244 | Advanced Breast... Anxiety CBD | Cannabidiol Placebo | 18 Years - | Dana-Farber Cancer Institute | |
| A Study to Investigate Behavioral and Other Co-Occurring Outcomes With Epidiolex as Add-On Therapy in Participants Aged 1 to 65 Years of Age With Tuberous Sclerosis Complex | NCT05864846 | Tuberous Sclero... | Cannabidiol Ora... | 1 Year - 65 Years | Jazz Pharmaceuticals | |
| Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution | NCT05044819 | Lennox Gastaut ... Dravet Syndrome Tuberous Sclero... | Cannabidiol | 1 Year - | Jazz Pharmaceuticals | |
| A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies | NCT03607643 | Cancer of Pancr... Cancer of Liver Cancer of Rectu... Cancer of Colon Cancer, Gall Bl... Myeloma Multipl... Glioblastoma Mu... | Cannabidiol Bortezomib Leucovorin 5-FU Oxaliplatin Bevacizumab Irinotecan Gemcitabine Temozolomide | 18 Years - 80 Years | Leaf Vertical Inc. | |
| CLDN6/GPC3/Mesothelin/AXL-CAR-NK Cell Therapy for Advanced Solid Tumors | NCT05410717 | Stage IV Ovaria... Testis Cancer, ... Endometrial Can... CAR NK | Claudin6, GPC3,... | 18 Years - 75 Years | Second Affiliated Hospital of Guangzhou Medical University | |
| NanaBis™ an Oro-buccal Administered delta9-Tetrahydrocannabinol (d9-THC) & Cannabidiol (CBD) Medicine for the Management of Bone Pain From Metastatic Cancers | NCT04808531 | Cancer Related ... | NanaBis™ Oxycodone CR Placebo Spray Placebo Tablet Oxycodone IR | 18 Years - 75 Years | Medlab Clinical | |
| Phytocannabinoids for the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors | NCT05672342 | Breast Carcinom... Chemotherapy-In... Colon Carcinoma | Cannabidiol Delta-8-Tetrahy... Placebo Adminis... Questionnaire A... | 18 Years - | City of Hope Medical Center | |
| Phytocannabinoids for the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors | NCT05672342 | Breast Carcinom... Chemotherapy-In... Colon Carcinoma | Cannabidiol Delta-8-Tetrahy... Placebo Adminis... Questionnaire A... | 18 Years - | City of Hope Medical Center | |
| A Study to Investigate Behavioral and Other Co-Occurring Outcomes With Epidiolex as Add-On Therapy in Participants Aged 1 to 65 Years of Age With Tuberous Sclerosis Complex | NCT05864846 | Tuberous Sclero... | Cannabidiol Ora... | 1 Year - 65 Years | Jazz Pharmaceuticals | |
| Investigating the Potential Role of a Novel Quadrate Combination Therapy Mifepristone(Antiprogestrone), Tamoxifen, Retinoic Acid and Cannabidiol ( Selective Cyp 26 Inhibitor) for Treating Early Breast Cancer. | NCT05016349 | Breast Cancer F... | All trans-retin... 13-Cis Retinoic... Mifepristone Cannabidiol 9 cis retinoic ... Tamoxifen Standard therap... | 18 Years - 70 Years | Kafrelsheikh University | |
| Investigating the Potential Role of a Novel Quadrate Combination Therapy Mifepristone(Antiprogestrone), Tamoxifen, Retinoic Acid and Cannabidiol ( Selective Cyp 26 Inhibitor) for Treating Early Breast Cancer. | NCT05016349 | Breast Cancer F... | All trans-retin... 13-Cis Retinoic... Mifepristone Cannabidiol 9 cis retinoic ... Tamoxifen Standard therap... | 18 Years - 70 Years | Kafrelsheikh University | |
| A Study to Investigate Behavioral and Other Co-Occurring Outcomes With Epidiolex as Add-On Therapy in Participants Aged 1 to 65 Years of Age With Tuberous Sclerosis Complex | NCT05864846 | Tuberous Sclero... | Cannabidiol Ora... | 1 Year - 65 Years | Jazz Pharmaceuticals | |
| Novel Cognitive Treatment Targets for Epidiolex in Sturge- Weber Syndrome | NCT04447846 | Sturge-Weber Sy... | Cannabidiol | 3 Years - 50 Years | Hugo W. Moser Research Institute at Kennedy Krieger, Inc. | |
| Assessment of Adjunctive Cannabidiol Oral Solution (GWP42003-P) in Children With Tuberous Sclerosis Complex (TSC), Dravet Syndrome (DS), or Lennox-Gastaut Syndrome (LGS) Who Experience Inadequately-controlled Seizures | NCT04485104 | Seizure in Part... Seizure in Part... Seizure in Part... | GWP42003-P | 1 Month - 23 Months | Jazz Pharmaceuticals | |
| An Observational Post-Marketing Safety Registry of Sativex® | NCT02073474 | Multiple Sclero... Diabetes Cancer Neuropathic Pai... | Sativex® | - | Jazz Pharmaceuticals | |
| RCT of CBD for Anxiety in Advanced Breast Cancer | NCT04482244 | Advanced Breast... Anxiety CBD | Cannabidiol Placebo | 18 Years - | Dana-Farber Cancer Institute | |
| Cannabidiol (CBD) for Treatment of Aromatase Inhibitor-Associated Arthralgias | NCT04754399 | Arthralgia Breast Cancer | Cannabidiol (CB... | 18 Years - | University of Michigan Rogel Cancer Center | |
| A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies | NCT03607643 | Cancer of Pancr... Cancer of Liver Cancer of Rectu... Cancer of Colon Cancer, Gall Bl... Myeloma Multipl... Glioblastoma Mu... | Cannabidiol Bortezomib Leucovorin 5-FU Oxaliplatin Bevacizumab Irinotecan Gemcitabine Temozolomide | 18 Years - 80 Years | Leaf Vertical Inc. | |
| The Use of Cannabidiol in Cancer Patients | NCT05407298 | Cancer | Non applicable | 18 Years - | CHU de Reims |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
